Drugs · acquisition-cost intelligence
Aleve-D Sinus and Cold
Naproxen sodium and Pseudoephedrine Hydrochloride· ingredient naproxenAntiinflammatory preparations, non-steroids for topical use· NAPROXEN SODIUM 220 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.24430
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 5 weeks.
2025-08-202026-05-20
Same-ingredient options by acquisition cost
Other naproxen products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Naproxen | $0.05893 | −$0.18540 |
| Naprotin | $0.06254 | −$0.18180 |
| 24/7 Life by 7-Eleven Naproxen Sodium | $0.06496 | −$0.17930 |
| Aleve | $0.14651 | −$0.09780 |
| Naproxen Oral Suspension | $0.17537 | −$0.06890 |
| Naproxen sodium | $0.22001 | −$0.02430 |
| Naproxen | $1.91 | +$1.66 |
| Naprelan | $9.28 | +$9.03 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.